The right stocks can make you rich and change your life.
The wrong ones can do a lot more than just underperform. They can eviscerate your wealth, bleeding out your hard-won profits one quarter at a time.
They’re pure portfolio poison.
Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media until it’s too late.
That’s not to say these are obscure companies. Some of the names we’re highlighting today are in the headlines every week, often in glowing terms. But beneath the surface, the numbers tell a different story.
This week, we’re looking at three stocks where the warning signs are hard to ignore. A cannabis company staring down another reverse split, a cybersecurity giant trading at a premium that may be tough to justify, and a training company that just missed earnings and cut guidance. Here’s what the data is showing.
Palo Alto Networks, Inc. (NASDAQ: PANW)
Palo Alto Networks is one of the most widely held cybersecurity stocks in the market. The company sits at the center of the AI-powered security conversation, and Wall Street generally loves the name. But the price action this week raised a flag worth paying attention to.
On Wednesday, Evercore ISI analyst Peter Levine raised his price target on Palo Alto from $320 to $415, citing strong free cash flow growth into 2027 and the company’s position in identity, observability, and AI-powered security operations. It was a bullish call from a credible analyst.
The stock dropped 4.9% the same day, closing at $321.12.
When a stock falls on positive analyst coverage, that’s worth noting. It suggests the market is already pricing in a very optimistic scenario, and even a significant price target hike isn’t enough to push shares higher. Levine’s target implies Palo Alto should trade at roughly 52 times next year’s projected free cash flow, with an implied fair value of about $338 billion. The consensus Wall Street estimate for 2027 free cash flow sits at $5.2 billion, while Levine’s target implies closer to $6.5 billion.
That gap between the bullish case and consensus estimates is where the risk lives. If Palo Alto grows into Levine’s numbers, the stock has room to run. If it falls short, 52 times free cash flow becomes a very expensive multiple to defend. The 52-week range runs from $139.57 to $368.17, which means the stock has already had a massive run and is trading near the top of that range. Premium valuations near 52-week highs are exactly where investors may want to take a closer look at what they’re actually paying for.
Canopy Growth Corporation (NASDAQ: CGC)
Canopy Growth is trading below $1 again. At $0.95 per share, the stock is back in dangerous territory for a Nasdaq-listed company.
The 52-week range tells the story: a high of $2.38, a low of $0.84. The stock is sitting just above its lowest point of the year, and the fundamental picture doesn’t offer much reason for a turnaround.
Canopy Growth has been here before. The company executed a 1-for-10 reverse stock split in December 2023 to get its share price above the $1 minimum Nasdaq listing requirement. Since then, the stock has fallen roughly 80%. Now it’s back below $1, and the same question is looming: will another reverse split be necessary?
Nasdaq gives companies 180 days to regain compliance if their stock stays below $1 for 30 consecutive business days. A reverse split is a mechanical fix, but it doesn’t address the underlying problem. Canopy Growth continues to incur losses, and its growth prospects remain weak. The company’s gross margin sits at just 17.48%, which is thin for a company that isn’t profitable.
The market cap has shrunk to roughly $402 million. Revenue isn’t growing fast enough to offset persistent losses, and the cannabis sector as a whole has been a difficult place for investors for years. Reverse splits are often a sign that a stock has been performing so poorly that the company needs to artificially boost its share price just to stay listed. That’s not a signal of strength.
For investors who held through the last reverse split hoping for a recovery, the 80% decline since December 2023 is a painful reminder that a lower share price doesn’t make a struggling business more attractive. Canopy Growth’s financials suggest the next reverse split may be a matter of when, not if.
Franklin Covey Co. (NYSE: FC)
Franklin Covey isn’t a name that makes headlines. The company provides training, consulting, and productivity services to organizations, and it flies under the radar of most investors. That’s exactly the kind of stock where weakness can go unnoticed until the damage is significant.
On July 1, Franklin Covey reported results for the third quarter of its 2026 fiscal year. The numbers disappointed. Earnings per share came in at $0.27 on revenue of $67.8 million, missing analyst estimates of $0.31 per share on roughly $68.3 million in revenue. Revenue did grow about 1% year over year, and earnings improved from a loss of $0.11 per share in the prior-year quarter, but the market was expecting more.
The stock dropped 12.9% the next day, closing at $19.54.
More concerning than the quarterly miss was the guidance cut. Franklin Covey lowered its full-year revenue target to a range of $260 million to $267 million, down from its previous range of $265 million to $275 million. The company also trimmed its adjusted EBITDA outlook, lowering the top end from $33 million to $31 million while keeping the bottom end at $28 million.
When a company misses on both revenue and earnings and then lowers guidance, it signals that management’s visibility into the business is deteriorating. Franklin Covey’s services are discretionary spending for its clients. When organizations tighten budgets, training and consulting are often the first expenses to get cut. The guidance reduction suggests that environment may be pressing on the business right now.
The 52-week range runs from $11.16 to $26.81, so the stock isn’t at its low for the year. But a 12.9% single-day drop on an earnings miss and guidance cut is the kind of move that often marks the beginning of a longer slide rather than a one-time adjustment. The market cap is just $244 million, which means lower trading volume can amplify price swings, and the stock may not get the attention it needs from buyers to stabilize quickly.
